Log in
Enquire now
‌

US Patent 8030313 Controlled release sterile injectable aripiprazole formulation and method

Patent 8030313 was granted and assigned to Otsuka Pharmaceutical on October, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Otsuka Pharmaceutical
Otsuka Pharmaceutical
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8030313
Date of Patent
October 4, 2011
Patent Application Number
11979149
Date Filed
October 31, 2007
Patent Citations Received
‌
US Patent 11786522 Aripiprazole injectable suspension formulation having prolonged shelf life
‌
US Patent 11931355 Aripiprazole formulations having increased injection speeds
0
‌
US Patent 11969469 Pharmaceutical compositions having improved storage stability
0
Patent Primary Examiner
‌
Yong Chong
Patent abstract

A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8030313 Controlled release sterile injectable aripiprazole formulation and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.